Myovant Sciences Ltd. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q1 2016 to Q4 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
-
Summary
-
Myovant Sciences Ltd. quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q1 2016 to Q4 2022.
- Myovant Sciences Ltd. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending December 31, 2022 was -$56.4M, a 10.7% increase year-over-year.
- Myovant Sciences Ltd. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending December 31, 2022 was -$162M, a 28.2% increase year-over-year.
- Myovant Sciences Ltd. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was -$201M, a 21.1% increase from 2020.
- Myovant Sciences Ltd. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2020 was -$255M, a 11.6% increase from 2019.
- Myovant Sciences Ltd. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2019 was -$288M, a 5.55% decline from 2018.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)